Continuum partners with social network to crowdsource late-stage clinical trials

By Melissa Fassbender contact

- Last updated on GMT

Skipta is social network of online medical communities for verified healthcare professionals. (Image: iStock/Jirsak)
Skipta is social network of online medical communities for verified healthcare professionals. (Image: iStock/Jirsak)

Related tags: Scientific method

Continuum Clinical has partnered with Skipta to expedite physician and patient participation in clinical trials.

Life sciences companies are increasingly undertaking ‘real world’ studies, but often encounter challenges in enlisting the participation of ‘real world’ physicians​ – i.e. not traditional clinical trialists​,” Jeff Trotter, president at Continuum Clinical told Outsourcing-Pharma.com.

To address this challenge, Continuum launched the Center for Observational Research, which combines Continuum’s experience in observational research with Skipta’s network of practicing physicians.

The companies are leveraging crowdsourcing for research sponsors looking for non-interventional study participants outside academic or clinical trial investigative sites.

Skipta members will be able to review an extensive listing of the observational studies in which Continuum is primarily involved in design and implementation, and be able to indicate their interest in potentially participating​,” explained Trotter.

Sponsors will benefit through expedited communications about physician (and patient) participation in these important research initiatives​,” he added.

Trotter told us they hope to achieve multiple benefits, including helping clients expedite observational studies and registries, in addition to providing research opportunities to practicing physicians. 

At the end of the day, more observational studies will be implemented and important findings on patient outcomes under actual practice conditions will become available​,” said Trotter.

The Center for Observational Research is now available to Skipta members.

Related topics: Clinical Development, Phase III-IV

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us

Products

View more

Webinars